ReviewISRN cardiology2013

Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin-Receptor Blockers (ARBs) in Patients at High Risk of Cardiovascular Events: A Meta-Analysis of 10 Randomised Placebo-Controlled Trials.

Hean Teik Ong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.